Related Articles
HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer
Precision medicine in breast cancer (Review)
BCL11A confers cell invasion and migration in androgen receptor‑positive triple‑negative breast cancer
Clinical significance of androgen receptor expression in triple negative breast cancer‑an immunohistochemistry study
Repurposing itraconazole as an anticancer agent (Review)